逆行性慢性全闭塞的进展 皮肤冠状动脉干预:技术,结果和不断发展的策略
Madeleine Barker1, Tony J De Martini2
1Division of Cardiology, Emory University Hospital, 1364 Clifton Road Northeast, Atlanta, GA 30322, USA.
Interventional cardiology clinics
|November 23, 2025
概括
逆行性慢性全封闭 (CTO) 穿皮冠状动脉干预 (PCI) 提高了复杂冠状动脉病变的成功率. 本综述详细介绍了安全有效的逆行CTO PCI技术,最大限度地减少并发症.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管医学 心血管医学
背景情况:
- 慢性全闭症 (CTOs) 在穿皮冠状动脉干预 (PCI) 中存在复杂的挑战.
- 逆行技术为CTO重血管化提供了一个替代方法.
研究的目的:
- 提供一个全面的实践审查的逆行CTO PCI.
- 概述逆行CTO PCI的征兆,技术和并发症管理.
主要方法:
- 对逆向访问和抵押品选择的指示的审查.
- 技术的详细描述:抵押交叉,电线升级和反向控制的前级和后级次极跟踪.
- 重点是尽量减少捐赠动脉创伤和管理并发症.
主要成果:
- 逆行性CTO PCI显著增加了复杂冠状动脉病变的成功率.
- 先进的技术和逐步的故障排除提高了安全性和可重复性.
- 这种技术在由熟练的干预专家执行时是有效的.
结论:
- 逆行性CTO PCI是复杂的冠状动脉病变的一个有价值的技术.
- 掌握逆行技术可以改善患者的治疗结果和程序的成功.
- 这次审查为干预专家提供了安全和成功逆行CTO PCI的必要知识.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Acute Coronary Syndrome IV: Interprofessional Care
203
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Angina IV: Management
222
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
222


